New drug aims to halt silent kidney damage
NCT ID NCT06797518
Summary
This study is testing whether adding an investigational oral drug called iptacopan to standard supportive care can reduce harmful immune activity and slow kidney damage in adults with IgA nephropathy. Researchers will compare kidney biopsies from 20 participants before and after 9 months of treatment to look for changes in specific markers of disease. The goal is to see if the drug helps control the underlying disease process.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOGLOBULIN A NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
CaRe Research
RECRUITINGChubbuck, Idaho, 83202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Central Florida Kidney Specialists
RECRUITINGOrlando, Florida, 32806, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
DaVita Clinical Research
RECRUITINGLas Vegas, Nevada, 89146, United States
Contact Email: •••••@•••••
Contact
-
Georgia Nephrology Research Inst
RECRUITINGLawrenceville, Georgia, 30046, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Novartis Investigative Site
RECRUITINGCABA, Buenos Aires, 1280, Argentina
-
Novartis Investigative Site
RECRUITINGCABA, Buenos Aires, 1425, Argentina
-
Novartis Investigative Site
RECRUITINGAshdod, 7747629, Israel
-
Novartis Investigative Site
RECRUITINGHadera, 3820302, Israel
-
Novartis Investigative Site
RECRUITINGHaifa, 3109601, Israel
-
Novartis Investigative Site
RECRUITINGNahariya, 2210001, Israel
-
Novartis Investigative Site
RECRUITINGKuala Lumpur, Selangor, 43000, Malaysia
-
OSU Wexner Medical Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Prolato Clinical Research Center
RECRUITINGHouston, Texas, 77054, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UCLA Medical Center
RECRUITINGLos Angeles, California, 90095, United States
Contact Email: •••••@•••••
Contact
-
University Hospitals Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.